Abstract
Transgenic mice carrying an internally deleted human type II collagen gene (COL2A1) were used to study bone growth and development. This mutation has previously been shown to disturb the development of collagen fibrils in articular cartilage, causing chondrodysplasia and osteoarthritis. Type II collagen expression in bones was investigated with immunohistochemistry. The development and mineralization of the skeleton and anthropometric measurements on bones were evaluated using X-rays and dynamic histomorphometry. Type II collagen was expressed in the cartilage of developing bones. The bones of transgenic mice were smaller compared with the controls. The bone mass remained almost unchanged in transgenic mice after 1 month of age, leading to differences of 47% in trabecular bone volume (P = 0.012) and 40% in trabecular thickness (P < 0.01) at the age of 3 months compared with controls. At the age of 3 months the eroded surface per bone volume was 31% greater in transgenic mice compared with controls (P < 0.05). Trabecular thickness correlated positively with body weight (R = 0.71, P < 0.001). Interestingly, body weight correlated with bone volume in control mice (R = 0.27, P < 0.01), but no correlation was observed in transgenic mice. The disturbed synthesis of cartilage-specific type II collagen in growing transgenic mice retarded bone development, increased bone resorption, and altered tissue properties. This led to a negative net bone balance and small bone size. The results support the idea that an altered synthesis of cartilage-specific molecule(s) can disturb postnatal bone development and growth.
Similar content being viewed by others
References
Burgeson RE, Nimni ME (1992) Collagen types: molecular structure and tissue distribution. Clin Orthop 282:250–272
Mayne R, Ala-Kokko L (2005) Collagen structure and function. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. Lippincott Williams & Wilkins, Philadelphia, pp 189–209
Prockop DJ, Kivirikko KI (1995) Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 64:403–434
Seghatoleslami MR, Lichtler AC, Upholt WB, Kosher RA, Clark SH, Mack K, Rowe DW (1994) Differential regulation of COL2A1 expression in developing and mature chondrocytes. Matrix Biol 14:753–764
Ala-Kokko L, Baldwin CT, Moskowitz RW, Prockop DJ (1990) Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci USA 87:6565–6568
Jimenez SA, Ala-Kokko L, Ahmad N, Baldwin C, Dharmavaram R, Reginato A, Knowlton R, Prockop DJ (1992) Type II collagen gene mutations in familial osteoarthritis. In: Kuettner K, Schleyerbach R, Peyron J, Hascall VC (eds) Articular cartilage and osteoarthritis. Raven Press, New York, pp 167–177
Vikkula M, Palotie A, Ritvaniemi P, Ott J, Ala-Kokko L, Sievers U, Aho K, Peltonen L (1993) Early-onset osteoarthritis linked to the type II procollagen gene. Arthritis Rheum 36:401–409
Arita M, Li SW, Kopen G, Adachi E, Jimenez SA, Fertala A (2002) Skeletal abnormalities and ultrastructural changes of cartilage in transgenic mice expressing a collagen II gene (COL2A1) with a Cys for Arg-alpha1–519 substitution. Osteoarthritis Cartilage 10:808–815
Garofalo S, Vuorio E, Metsäranta M, Rosati R, Toman D, Vaughan J, Lozano G, Mayne R, Ellard J, Horton W, de Crombrugghe B (1991) Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci USA 88:9648–9652
Metsäranta M, Garofalo S, Decker G, Rintala M, de Crombrugghe B, Vuorio E (1992) Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro(alpha)1(II) collagen chain. J Cell Biol 118:203–212
Savontaus M, Metsäranta M, Vuorio E (1996) Retarded skeletal development in transgenic mice with a type II collagen mutation. Am J Pathol 149:2169–2182
Puustjärvi K, Nieminen J, Räsänen T, Hyttinen M, Helminen HJ, Kröger H, Huuskonen J, Alhava E, Kovanen V (1999) Do more highly organized collagen fibrils increase bone mechanical strength in loss of mineral density after one-year running training? J Bone Miner Res 14:321–329
Silva MJ, Brodt MD, Wopenka B, Thomopoulos S, Williams D, Wassen MH, Ko M, Kusano N, Bank RA (2006) Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse. J Bone Miner Res 21:78–88
Kaarniranta K, Ihanamäki T, Sahlman J, Pulkkinen H, Uusitalo H, Arita M, Tammi R, Lammi MJ, Helminen HJ (2006) A mouse model for Stickler’s syndrome: ocular phenotype of mice carrying a targeted heterozygous inactivation of type II (pro)collagen gene (Col2a1). Exp Eye Res 83:297–303
Francomano CA, Liberfarb RM, Hirose T, Maumenee IH, Streeten EA, Meyers DA, Pyeritz RE (1987) The Stickler syndrome: evidence for close linkage to the structural gene for type II collagen. Genomics 1:293–296
Wilkin DJ, Mortier GR, Johnson CL, Jones MC, de Paepe A, Shohat M, Wildin RS, Falk RE, Cohn DH (1998) Correlation of linkage data with phenotype in eight families with Stickler syndrome. Am J Med Genet 80:121–127
Helminen HJ, Kiraly K, Pelttari A, Tammi MI, Vandenberg P, Pereira R, Dhulipata R, Khillan JS, Ala-Kokko L, Hume EL, Sokolov BP, Prockop DJ (1993) An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). J Clin Invest 92:582–595
Helminen HJ, Säämänen AM, Salminen H, Hyttinen MM (2002) Transgenic mouse models for studying the role of cartilage macromolecules in osteoarthritis. Rheumatology (Oxford) 41:848–856
Hyttinen MM, Töyräs J, Lapveteläinen T, Lindblom J, Prockop DJ, Li SW, Arita M, Jurvelin JS, Helminen HJ (2001) Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer. Ann Rheum Dis 60:262–268
Li S-W, Prockop DJ, Helminen H, Fässler R, Lapveteläinen T, Kiraly K, Pelttari A, Arokoski J, Lui H, Arita M, Khillan JS (1995) Transgenic mice with targeted inactivation of the COL2A1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev 9:2821–2830
Nieminen J, Sahlman J, Hirvonen T, Jämsä T, Tuukkanen J, Kovanen V, Kröger H, Jurvelin J, Arita M, Li SW, Prockop DJ, Hyttinen MM, Helminen HJ, Lapveteläinen T, Puustjärvi K (2005) Abnormal response to physical activity in femurs after heterozygous inactivation of one allele of the Col2a1 gene for type II collagen in mice. Calcif Tissue Int 77:104–112
Sahlman J, Inkinen R, Hirvonen T, Lammi MJ, Lammi PE, Nieminen J, Lapveteläinen T, Prockop DJ, Arita M, Li SW, Hyttinen MM, Helminen HJ, Puustjärvi K (2001) Premature vertebral endplate ossification and mild disc degeneration in mice after inactivation of one allele belonging to the Col2a1 gene for type II collagen. Spine 26:2558–2565
Sahlman J, Pitkänen MT, Prockop DJ, Arita M, Li SW, Helminen HJ, Långsjö TK, Puustjärvi K, Lammi MJ (2004) A human COL2A1 gene with an Arg519Cys mutation causes osteochondrodysplasia in transgenic mice. Arthritis Rheum 50:3153–3160
Vandenberg P, Khillan JS, Prockop DJ, Helminen H, Kontusaari S, Ala-Kokko L (1991) Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc Natl Acad Sci USA 88:7640–7644
Prockop DJ (1990) Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. J Biol Chem 265:15349–15352
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Tsangari H, Findlay DM, Fazzalari NL (2007) Structural and remodeling indices in the cancellous bone of the proximal femur across adulthood. Bone 40:211–217
Weinstein RS, Manolagas SC (2000) Apoptosis and osteoporosis. Am J Med 108:153–164
Malluche HH, Faugere M-C (1986) Atlas of mineralized bone histology. Karger, Basel
Acknowledgments
This study was supported by the Research Foundation of Orthopedics and Traumatology in Finland, the Academy of Finland, and the Ministry of Education in Finland.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nieminen, J., Sahlman, J., Hirvonen, T. et al. Disturbed Synthesis of Type II Collagen Interferes with Rate of Bone Formation and Growth and Increases Bone Resorption in Transgenic Mice. Calcif Tissue Int 82, 229–237 (2008). https://doi.org/10.1007/s00223-008-9110-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-008-9110-0